---
title: "YBGJ.US (YBGJ.US) — 相关新闻"
type: "Symbol"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/quote/YBGJ.US/news.md"
symbol: "YBGJ.US"
name: "YBGJ.US"
parent: "https://longbridge.com/zh-CN/quote/YBGJ.US.md"
datetime: "2026-03-12T17:32:32.578Z"
locales:
  - [en](https://longbridge.com/en/quote/YBGJ.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/YBGJ.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/YBGJ.US/news.md)
---

> 支持的语言: [English](https://longbridge.com/en/quote/YBGJ.US/news.md) | [繁體中文](https://longbridge.com/zh-HK/quote/YBGJ.US/news.md)


# YBGJ.US (YBGJ.US) — 相关新闻

### [Bank of China BoC Pay+ launches cross-border consumption discounts](https://longbridge.com/zh-CN/news/278859640.md)
*2026-03-12T10:02:19.000Z*
> Bank of China Hong Kong launched the BoC Pay+ application in cooperation with UnionPay International, becoming the first

### [Shocking the medical venture capital circle! 100 female entrepreneurs created 30 IPOs, securing nearly 10 billion in financing](https://longbridge.com/zh-CN/news/278246247.md)
*2026-03-08T03:44:04.000Z*
> In China's healthcare venture capital circle, 100 female entrepreneurs have successfully driven 30 companies to IPO, rai

### [Bure Equity Hit by Sharp NAV Decline as Tech Portfolio Repriced in 2025](https://longbridge.com/zh-CN/news/276316837.md)
*2026-02-19T09:03:01.000Z*
> Bure Equity AB reported a significant decline in net asset value per share, falling 19.8% to SEK 267.2 in 2025, with tot

### [Emperor International Investment disclosed that the new co-chairman Wang Jun is the chairman of the US-listed company Yubo](https://longbridge.com/zh-CN/news/272334422.md)
*2026-01-13T00:01:00.000Z*
> Emperor International Investment disclosed information about the new executive director and co-chairman of the board, Wa

### [King International Investment Adds Governance Details on New Co-Chairman Wang](https://longbridge.com/zh-CN/news/272330038.md)
*2026-01-12T23:11:23.000Z*
> King International Investment Limited has disclosed additional details regarding the appointment of Mr. Wang as co-chair

### [Yubo International Biotech Limited | 10-Q: FY2025 Q3 Revenue: USD 0](https://longbridge.com/zh-CN/news/265904929.md)
*2025-11-14T11:14:26.000Z*
### [Yubo International Biotech Limited | 10-Q: FY2025 Q2 Revenue: USD 0](https://longbridge.com/zh-CN/news/252915262.md)
*2025-08-13T20:19:30.000Z*
### [Yubo International Biotech Limited | 10-Q: FY2025 Q1 EPS: USD 0](https://longbridge.com/zh-CN/news/240136813.md)
*2025-05-14T10:04:58.000Z*